About PathwayWorld  |  Strand Life Sciences  |  Contact Us
  • Search Pathways

    (e.g. Lung Cancer, Diabetes)

    'Search Tips'

    Use
    1. " " or AND for exact match,
    2. * for partial match


Analysis Pipeline


'Pathway Search Results'

Selection criteria for significant gene list :
Significant genes are selected with a p value cut-off of 0.1. The resultant list was then sorted in a descending order of fold change value. From the sorted list, the top 100 genes were selected for pathway/network. If the gene list is less than 100, the entire gene list was taken for pathway/network analysis.

>>Total hits : 2 , Search term given : Atrial AND Fibrillation

  Permanent atrial fibrillation (HG-U133B)

GEO Description :
Analysis of atrium from patients with permanent atrial fibrillation (AF). AF is associated with extensive structural, contractile, and electrophysiological remodeling. Results identify adoption of a ventricular-like genomic signature as a general feature of the fibrillating atrium.
Organism : Homo sapiens
GEO-ID : GDS1559

Compared Group :
no atrial fibrillation Vs permanent atrial fibrillation
  • Number of Nodes in the Network : 13
  • Number of Nodes passing Cut-Off : 100
  • PValue Cut-Off : 1.17467448035313e-06
  • Fold Change Cut-Off : 2.06
Compared Group :
ventricle Vs atrium
  • Number of Nodes in the Network : 8
  • Number of Nodes passing Cut-Off : 100
  • PValue Cut-Off : 1.33588701125997e-17
  • Fold Change Cut-Off : 2.23







DISCLAIMER:
The interactions, networks, list of genes/molecules or any other information presented here, is HYPOTHETICAL in nature and is based on information collected from public as well as other sources, and is analyzed by certain automated mining and analysis software workflows. Strandlife Science Pvt.Ltd. or the Editors of PathwayWorld offer this information with NO CLAIMS of accuracy and WARRANTIES of any kind, and DO NOT Accept liability or legal responsibility for losses allegedly caused by using this information.

GeneSpring® is a registered trademark of Agilent Technologies.
GeneSpring® is developed on AVADIS™ from Strand Life Sciences